Time	Talk Title	Faculty
07:00-07:45	Registration and Coffee	Michael G. Fehlings & Geoffrey Manley
07:45-08:00	PSC1.01: Welcome Remarks and Course Introduction	Michael G. Fehlings & Geoffrey Manley
08:00-08:15	PSC1.02: Welcome from: Global Neuro; AONA, AOSpine and NREF	Paul Manson, James Harrop & Shelly Timmons
Module 1 08:15-12:00	Traumatic Brain Injury and Cranial Trauma	Moderator: Geoffrey Manley
08:15-08:45	PSC1.03: Traumatic Brain Injury and Cranial Trauma	John Povlishock
08:45–09:15	PSC1.04: Clinical Translational Advances in Traumatic Brain Injury	Geoffrey Manley
09:15–09:45	PSC1.05: Advanced Techniques in Cranial Reconstruction	Paul Manson
09:45–10:15	PSC1.06: Decompressive Craniectomy	Peter Hutchinson
10:15-13:30	Coffee and Networking Break
10:30–11:00	PSC1.08: Critical Care of Traumatic Brain Injury in Adults and Children	Andrew Baker & Jamie Hutchinson
11:00–11:30	PSC1.09: Management of Traumatic Brain Injury in Children	Anthony Figaji
11:30–12:30	PSC1.10: Traumatic Brain Injury and Cranial Trauma	Shelly Timmons
12:30-12:45	Networking Break and Pick Up of Boxed Lunch
12:45–13:30	PSC1.12: Luncheon Seminars - An International Perspective on Traumatic Brain Injury - Biomarkers for Spinal Cord Injury - Discussion	Andrew Maas & Brian Kwon
Module 2 13:30-17:30	Spine Trauma and Spinal Cord Injury	Moderator: Michael G. Fehlings
13:30–14:00	PSC1.13: Spine Trauma and Spinal Cord Injury	Dalton Dietrich
14:00–14:30	PSC1.14: Clinical Translational advances in Spinal Cord Injury	Michael G. Fehlings
14:30–15:00	PSC1.15: Assessment & Management of Spinal Cord Injury	James Harrop
15:00–15:30	PSC1.16: Critical Management of Spinal Cord Injury (including review of the AO Spine Guidelines)	Greg Hawryluk
15:30-15:45	Coffee and Networking Break
15:45–16:30	PSC1.18: Panel: Role and Timing of Surgery in Spinal Cord Injury Moderator: Michael Fehlings	Michael G. Fehlings Bizhan Aarabi James Harrop Eve C. Tsai Brain Kwon Jefferson Wilson Mark Kotter Shekar Kurpad
16:30–17:30	PSC1.19: Panel: Management of Complex Thoracolumbar Spine Trauma Moderator: James Harrop	James Harrop Jefferson Wilson Bizhan Aarabi Brian Kwon Eve C. Tsai Mark Kotter David Okonkwo
17:30-19:00	Networking Cocktail Reception

Proposed Program

Time	Talk Title	Faculty
07:30	AANS/ CNS Breakfast
	Neurotrauma History and Guidelines Updates	Moderator: Eve C. Tsai
08:30	PSC2.01: Brain Injury Guidelines History and Update	David Onkonkwo
08:50	PSC2.02: Neurotrauma History and Guidelines Updates	Charles Tator
09:10	PSC2.03: Neurotrauma History and Guidelines Updates	Michael G. Fehlings
09:30	PSC2.04: Pediatric Trauma History and Guidelines Update	David Adelson
09:50	PSC2.05: Questions
10:00	Coffee Break
	Should ICP Monitoring be Continued?	Moderator: Alan Hoffer
10:30	PSC2.07: Case Presentation - Patient with Bifrontal Confusions, No Signification Hemorrhagic Lesion	Alan Hoffer
10:35	PSC2.08: Pro	Greg Hawryluk
10:45	PSC2.09: Con	Dan Michael
10:55	PSC2.10: Discussion and Verdict
	Surgical Treatment of Elderly with Odontoid Fracture	Moderator: Alan Hoffer
11:00	PSC2.11: Case Presentation	Jamie Wilson
11:05	PSC2.12: Pro	Jeff Wilson
11:15	PSC2.13: Con	James Harrop
11:25	PSC2.14: Discussion and Verdict
	Stem Cells for Clinical Neural Repair: Ready for Prime Time?	Moderator: Alan Hoffer
11:30	PSC2.15: Case Presentation - Patient with Spinal Cord Injury and Cystic Cavity	Stephanie de Vere
11:35	PSC2.16: Pro	Ann Parr
11:45	PSC2.17: Con	Eve C. Tsai
11:55	PSC2.18: Discussion and Verdict
12:00	Lunch
	Cutting Edge Trauma Management of Brain and Spinal Injuries	Moderator: Tuan Bui
13:00	PSC2.20: Military Management of Brain and Spinal Injuries	Christopher Neil
13:20	PSC2.21: Intraspinal Monitoring and Dural Decompression for Spinal Cord Injury	Marios Papadopoulous
13:40	PSC2.22: Anticoagulation and Trauma	Suzanne Tharin
14:00	PSC2.23: Machine Learning to Improve Neurosurgery	Uzma Samadani
14:20	Questions
14:40	AANS/ CNS Coffee Break
	Chronic Subdural Hematoma and Steroids	Moderator: Fahad Alkherayf
15:00	PSC2.24: Case Presentation	Kevin Kwan
15:05	PSC2.25: Pro	Roxanne Todor
15:15	PSC2.26: Con	Jamie Ullman
15:25	PSC2.27: Discussion and Verdict	Kevin Kwan
	Management of a Thoracolumbar Burst Fracture	Moderator: Fahad Alkherayf
15:30	PSC2.28: Case Presentation - Patient with Burst Fracture, Neurologically Intact	Mohammed Alswat
15:35	PSC2.29: Nonsurgical	Brian Kwon
15:45	PSC2.30: Surgical	Paul Arnold
15:55	PSC2.31: Discussion and Verdict	Mohammed Alswat
	Is Decompressive Craniotomy Beneficial?	Moderator: Fahad Alkherayf
16:00	PSC2.32: Case Presentation	Ziyad Makoshi
16:05	PSC2.33: Pro	Peter Hutchison
16:15	PSC2.34: Con	Shelly Timmons
16:25	PSC2.35: Discussion and Verdict	Ziyad Makoshi

Click here for further details.

Supported by Codman Specialty Surgical

Join us for the Welcome Reception and to mix and mingle with sponsors & exhibitors, colleagues and friends while enjoying local wines, beers and small snacks.

*Included in the registration fee for delegates.

supported by

Click here for further details.

Supported by Fortuna Fix

 

Chair: Michael G. Fehlings, Canada

• P1.01: Repair and Regeneration of the Injured Spinal Cord: Clinical Translation Advances - Michael G. Fehlings, Canada
• P1.02: Rescuing the Injured Brain - Peter Hutchinson, United Kingdom
• P1.03: Recent advances in protection and repair after Spinal Cord Injury - Dalton Dietrich, United States
• P1.04: Evidence for Neocortical Circuit Disruption following Mild Traumatic Brain Injury - John T. Povlishock, United States

Refreshments supported by

Chair: Andrew Maas, Belgium

• S1.01: Approaches to outcome assessment in TBI: Challenges and opportunities - Andrew Maas, Belgium
• S1.02: Outcome after TBI across Europe - Nicole von Steinbüchel, Germany
• S1.03: Sensitive Assessment after Traumatic Tetraplegia with a focus on the Upper Limb: Do we Really Understand the Natural History of Disease? - Sukhvinder Kalsi-Ryan, Canada
• S1.04: Outcomes and prediction in acute spinal cord injury - Armin Curt, Switzerland

Chair: Susan Harkema, United States

• S2.01: Functional Electrical Stimulation Therapy for Improving Voluntary Grasping Function Following SCI - Milos Popovic, Canada
• S2.02: A continuum of strategies for neuroplasticity and recovery using epidural stimulation after spinal cord injury - Susan Harkema, United States
• S2.03: Activation of Spinal Networks for Improving Mobility after Spinal Cord Injury - Vivian Mushawar, Canada

Chair: David Okonkwo, United States

• S3.01: Michael J. Bell, United States
• S3.02: TEAM-TBI: Targeted Evaluation, Action and Monitoring of Traumatic Brain Injury - David Okonkwo, United States
• S3.03: Track-TBI - Geoffery Manley, United States
• S3.04: Andrew Maas, United States

Click here for further details.

Supported by:

Chairs: David Morilak, United States &, Patricia de la Tremblaye, United States

• P2.01: Stress-related cognitive impairment and therapeutic response may influence the course of decline and recovery from TBI - David Morilak, United States
• P2.02: Interaction of brain trauma and chronic unpredictable stress on cognition, anxiety, and markers of neurotransmission and neuroinflammation - Corina Bondi, United States
• P2.03: Early life stress increases vulnerability to experimental brain injury - Naima Lajud Avila, Mexico
• P2.04: Chronic outcomes in a mouse model of repeated, unpredictable stress - Fiona Crawford, United States

Chair: Isobel A. Scarisbrick, United States

• S4.01: Ketogenic diet for acute spinal cord injury - Wolfram Tetzlaff, Canada
• S4.02: Metabolic Links Between Exercise and Dietary Fat Regulate Myelin in the Adult CNS: Implications for Recovery after SCI - Isobel A. Scarisbrick, United States
• S4.03: Axon-myelin Interactions in Traumatic White Matter Injury - Regina Armstrong, United States
• S4.04: The interplay between brain and gut in the pathophysiology of brain trauma - Fernando Gomez-Pinilla, United States

Chair: Jerry Silver, United States

• S5.01: Rapid and robust recovery of breathing long after spinal cord injury - Jerry Silver, United States
• S5.02: Rescuing the Fate of Neural Progenitor Transplants in Spinal Cord Injury Niche via Attenuation of Notch Signaling with GDNF - Mohamad Khazaei, Canada
• S5.03: Directly reprogrammed human oligodendrogenic neural progenitor cells delivered with chondroitinase ABC facilitate functional repair of chronic spinal cord injury - Satoshi Nori, Japan
• S5.04: Enhancing plasticity for functional recovery after spinal cord injury - Jessica Kwok, United Kingdom

Chair: Ramona Hicks, United States

• S6.01: The International TBI Research Initiative - Five Years On! - Ramona Hicks, United States
• S6.02: Historical and Future Perspectives on InTBIR - Andrew Maas, United States
• S6.03: Neuroimaging Biomarkers: The power of standardization and collaboration - Stephan Strother, Canada
• S6.04: Genomics and Proteomics: The power of standardization and collaboration - Ramon Diaz-Arrastia, United States
• S6.05: Translating Knowledge to Practice: Scenarios for Sustained International Cooperation in TBI Research - Elizabeth Theriault

Join our Poster Mixers and discuss the latest research and innovations with your fellow colleagues and friends. Enjoy a drink and small snacks while networking.

Click here for further details.

Supported by

Simone Di Giovanni, United Kingdom

• P3.01: - Samuel David
• P3.02 Injury dependent and independent signalling for the control of axonal regeneration - Simone di Giovanni, United Kingdom
• P3.03: Biomaterial bridge-mediated facilitation of axonal regeneration and recovery in acute and chronic spinal cord injury - Aileen Anderson, United States
• P3.04: RGMa neutralization promotes functional recovery following spinal cord injury - Philippe Monnier, Canada
• P3.05: dI3 interneurons: a target for neuroplasticity and regeneration for recovery of locomotor function - Tuan Bui, Canada

Chair: Brian Kwon, Canada

• S7.01: An update on Diagnostic and Prognostic Biomarkers for Traumatic Brain injury - Kevin K.W. Wang, United States
• S7.02: Biomarkers of Acute Spinal Cord Injury - Brian Kwon, Canada
• S7.03: MicroRNA Biomarkers Predict Degenerative Cervical Myelopathy Severity and Surgical Outcome - Alex Laliberte, Canada
• S7.04: Moving from Estimates to Clinical Impact: a Systematic Analysis of the Use of Blood-based Biomarkers in the Field of Traumatic Brain Injury - Stefania Mondello, Italy

Chair: Alan Faden, United States

• S8.01: New immunomodulatory targets for spinal cord injury - Soheila Karimi, Canada
• S8.02: Sustained Neuroinflammation and Progressive Neurodegeneration after TBI or SCI: Mechanisms and Modulation - Alan Faden, United States
• S8.03: Age-dependent neuroinflammation: The role of macrophages in SCI recovery - John Gensel, United States
• S8.04: Matrix metalloproteinases and Spinal Cord Injury: Deciphering their complex roles in neurological and urological recovery - Linda Noble-Haeusslein, United States

Chair: Bevan Main, United States

• DB1.01.01: Direct Comparison of Adult Human and Rat Spinal Cord Stem/Progenitor cell Response to Inflammatory and Regenerative Cues - Ahmad Galuta, Canada
• DB1.02.01: Molecular Pain Targets In Rodent and Human Spinal Cord: Implications for Translation of Novel Therapies for Traumatic Pain - Chaya Kandegedara, Canada
• DB1.03.01: AMPA Receptor Modulation as a Therapeutic Strategy to Enhance Survival of Spinal Cord Neural Stem Cells - Laureen Hachem, Canada
• DB1.03.02: IP3R-mediated intra-axonal Ca2+ release contributes to secondary axonal degeneration following contusive SCI - Nicolas Pelisch, United States
• DB1.03.03: Naltrexone amplifies disruption in locomotor function following hindlimb stretching in rats with spinal cord injuries - Gregory States, United States
• DB1.03.04: Regional and Institutional Practice Variations in Penetrating Spinal Cord Injury in the United States - Pranay Soni, United States
• DB1.03.05: Oligogenic Directly Reprogrammed NPCs Combine with Affinity-Release ChABC to Regenerate the Chronically Injured Spinal Cord - Christopher Ahuja, Canada
• DB1.04.01: DNA damage induces early brain aging after traumatic brain injury - Nicole Schwab, Canada
• DB1.04.02: A New Class of Carbon Antioxidants Restored Cerebral Perfusion in Traumatic Brain Injury Complicated by Systemic Hypotension - Kimberly Mendoza, United States
• DB1.04.03: ENIGMA Military Brain Injury: Framework and Preliminary dMRI Meta-analysis - Emily Dennis, United States
• DB1.04.04: Effects of pituitary function on long-term health outcomes following mTBI in service members treated at the CRCC - Stephanie Ciarlone, United States
• DB1.04.05: CLARITY reveals less disconnection of axons than previously thought and a more prolonged process of degeneration after TBI - Maura Weber, United States
• DB1.04.06: Characterization of EPO/EPOr expression and activation before and after TBI with delayed hypoxemia - Marta Celorrio, United States
• DB1.04.07: High-G head collisions are associated with short-term white matter microstructural deficits in high school football athletes - Yukai Zou, United States
• DB1.04.08: Inhibition of TLR4 with C34 attenuates the neuroinflammatory response to traumatic brain injury - Young Chun, United States
• DB1.04.09: Acute mitochondrial impairment underlies prolonged cellular dysfunction after repeated mild traumatic brain injuries - William Hubbard, United States
• DB1.04.10: GABAergic synapse degeneration after mild traumatic brain injury in mice - Michal Vascak, United States
• DB1.04.11: Sex differences in acute neurodegeneration and sustained impairment of axonal function following diffuse TBI in mice - Jennifer Creed, United States

Click here for further details.

Supported by:

Theme: Global Trends in Translational Neurotrauma Research

3:30 - 5:30 pm	Scientific Program:
3:30 - 3:35 pm	Welcome remark (Ping Wu) Introduction of speakers (Shuxin Li & Dong Sun)
3:35 – 4:05 pm	Prof. Bing Song, Cardiff Univ., UK “Electrical signals in controlling cell migration and stem cell behavior for SCI”
4:05 – 4:35 pm	Prof. Wai S. Poon, 潘偉生 Chinese University of Hong Kong, Hong Kong “Translational cell-based therapies from animal models to human TBI and SCI: Practical considerations”
4:35 – 5:05 pm	Prof. Baiyun Liu, 刘佰运 Tiantan Hospital, Beijing, China “Chinese Technical Guidelines for Large Decompressive Craniectomy in Adult Patients with Severe Traumatic Brain Injury”
5:05 – 5:35 pm	Dr. Jason Huang, M.D., Baylor Scott & White Health in Temple, TX. “Management of Blast-Related Traumatic Brain Injury with a Review of Combat Neurosurgical Experience”
5:35 – 5:40	Closing remark (Kevin Wang & Xiaoming Xu)
5:40 – 6:00	CNSA Business Meeting (Ping Wu)
6:30 pm	CNSA Networking Dinner (all are welcome, pay on your own)

 

Chair: Virginia Newcombe, United Kingdom

• P4.01: Standardization of acquisition and data processing in spinal cord MRI: Application in degenerative cervical myelopathy - Julien Cohen-Adad, Canada
• P4.02: Advanced imaging methods: what is on the horizon? - Claudia Wheeler-Kingshott, United Kingdom
• P4.03: Advanced imaging methods: what is on the horizon? - David Menon, United Kingdom
• P4.04: Early MRI after TBI: more than an image - Virginia Newcombe, United Kingdom

Chair:Mark Kotter, United Kingdom

• S9.01: Cell transplantation for Spinal Cord Injury - an overview of clinical Trials - Mark Kotter, United Kingdom
• S9.02: Mesenchymal stem cells in a nanofiber-hydrogel composite matrix for spinal cord repair - Martin Oudega, United States
• S9.03: Stimulating endogenous neural precursors to promote self repair of the injured CNS - Cindi Morshead, Canada
• S9.04: Application of human neural precursor cells for spinal cord injury – from bench to bedside - Narihito Nagoshi, Japan

Chair: Corina Bondi, United States

• S10.01: Does Brain Stimulation Enhance Rehabilitation Efficacy after TBI? - DeAnna L. Adkins, United States
• S10.02: Grace Griesbach, United States
• S10.03: Optimizing environmental enrichment to model preclinical neurorehabilitation - Jeffrey Cheng, United States
• S10.04: Neural Plasticity and Neurorehabilitation following TBI in the Rat: Translation to the Clinic? - Dorothy Kozlowski, United States

Chair: Chris Ahuja, Canada

• DB2.03.01: Projection specific mechanisms of auditory sensitivity that contribute to enhanced fear after TBI - Ann Hoffman, United States
• DB2.03.02: 5-HT1f receptor agonists induce mitochondrial biogenesis and promote recovery from spinal cord injury - Epiphani Simmons, United States
• DB2.03.03: Pathological patterns of spinal cord blood flow after injury visualised with laser speckle contrast imaging - Mathew Gallagher, United Kingdom
• DB2.03.04: Drug Re-purposing: High Dose Human Immunoglobulin G for Treatment of Traumatic Cervical Spinal Cord Injury - Jonathan Chio, Canada
• DB2.03.05: MIS416 enhances recovery from traumatic spinal cord injury (SCI) in mice by regulating the innate immune response - Masoud Hassanpour Golakani, Australia
• DB2.04.01: Associations of Head Injury with Risk of Mortality, Incident Coronary Heart Disease, Stroke, and Heart Failure - Andrea Schneider, United States
• DB2.04.02: Sensory Hypersensitivities in Patients with Persistent Post-Traumatic Headache vs. Migraine - Jeffery Hanna, United States
• DB2.04.03: Cognitive training improves neural efficiency in TBI - Kihwan Han, United States
• DB2.04.04: Investigating the Neurological Effects of Sleep Deprivation on Post Concussion Symptomology in Adolescent Rats - Sabrina Salberg, Canada
• DB2.04.05: Traumatic brain injury-induced neuronal damage induces cortical rod microglia that promote persistent neuroinflammation - Kristina Witcher, United States
• DB2.04.06: Prognostic inflammatory biomarkers for traumatic brain injury: A TRACK-TBI Pilot Study - Margalit Haber, United States
• DB2.04.07: Individualized brain network architecture distinguishes TBI-associated depression from TBI, major depression, and PTSD - Shan Siddiqi, United States
• DB2.04.08: Catastrophic disruption of the blood-brain barrier in pediatric TBI - Josie Fullerton, UK
• DB2.04.09: Reprogramming Monocyte-Derived Macrophages to Mitigate Secondary Injury Pathology Following Traumatic Brain Injury - Kathryn Wofford, United States
• DB2.04.10: Diagnostic utility of GFAP for identifying TBI patients with MRI abnormalities despite normal head CT: A TRACK-TBI study - John Yue, United States
• DB2.04.11: Repetitive Transcranial Magnetic Stimulation with Resting State Network Targeting for Treatment-Resistant Depression in TBI - Shan Siddiqi, United States
• DB2.04.12: Variation in Structure and Process of Care in Traumatic Brain Injury: Provider Profiles in the CENTER-TBI Study - Maryse Cnossen, Netherlands
• DB2.04.13: Temporal lobe contusions are associated with impaired six-month functional recovery after mild TBI: A TRACK-TBI study - John Yue, United States
• DB2.04.14: Multimodal assessment of behavioral flexibility after frontal brain trauma: beneficial effects of milnacipran - Timothy Craine, United States
• DB2.04.15: Three-dimensional interrogation of traumatic axonopathy in the brain identifies SARM1 as major driver of axonal degeneration - Nikolaos Ziogas, United States
• DB2.04.16: Sleep-wake cycle deregulation despite normal circadian clock signal in acute traumatic brain injury - Catherine Duclos, Canada
• DB2.04.17: Evaluation and evolution of the olfactory system within the first 24 hours after a mild traumatic brain injury (mTBI). - Fanny Lecuyer Giguere, Canada
• DB2.04.18: Modeling of Traumatic Brain Injury (TBI) due to Head Impacts with Unmanned Aircraft Systems (UAS) - Anna Marie Dulaney, United States

Click here for further details.

Supported by

Chair: Ross Zafonte, United States

• P5.01: Control of Reaching and Grasping following SCI - Monica Perez, United States
• P5.02: The placebo response: the role of the rouse in rehabilitation - Ross Zafonte, United States
• P5.03: Neural control of locomotor outcomes in human SCI - Armin Curt, Switzerland
• P5.04: Post-Traumatic Epilepsy: Personal Biology, Clinical Predictors, and Disability Burden - Amy Wagner, United States

Chair: Robert Clark, United States

• S11.01: Robert Clark, United States
• S11.02: Neuroinflammation: how aging impacts microglial function following acute brain trauma - David Loane, United States
• S11.02: Frequency-Dependent Changes in Resting State EEG Functional Networks in Piglets after Rapid Head Rotations - Implications for Identifying Mild Brain Injury Across the Lifespan - Susan Margulies, United States
• S11.03: Progressive neuropathology and the emergence of behavior deficits after pediatric TBI - Bridgette Semple, Australia
• S11.04: Gut microbiota are disease modifying factors after spinal cord injury - Kristina Kigerl, United States

Chair: Greg Hawryluk, United States

• S12.01: Greg, Hawryluk, United States
• S12.02: Jan Schwab, United States
• S12.03: Role of Baseline Magnetic Resonance Imaging in Clinical Decision Making and Outcome Prediction (clinical update) - Bizhan Aarabi, United States
• S12.04: The SPRING Study: A Phase 2b/3 Study of the Efficacy and Safety of VX-210 in Subjects with Acute Cervical Spinal Cord Injury: Study Design, Status, and Baseline Characteristics - Marco Rizzo, United States
• S12.05: Translation of self-delivering RNA to silence PTEN and promote axon regeneration after neurotrauma - Lisa Mckerracher, United States

Chair: Michael G. Fehlings, Canada

• PP1.01: My Story-Hope - Tara Jeji, Canada
• PP1.02: Creative Fund Development for SCI Research - Barry Munro, Canada
• PP1.03: ONF as the Catalyst in Acquired Brain Injury: Working With Providers, Patients and Planners - Corinne Kagan , Canada

Join our Poster Mixers and discuss the latest research and innovations with your fellow colleagues and friends. Enjoy a drink and small snacks while networking.

Enjoy an evening with your friends and fellow colleagues. Don't miss a cocktail reception accompanied by a jazz quartet followed by a 3-course meal. We will also honor our Award Winners during this festive evening. Last, but not least we would like to invite you to shake a leg to the tones of a rock and pop after dinner.

*Tickets are not included in the registration fee and have to purchased separately.

supported by

Chair: Anthony Figaji, South Africa

• P6.01: Challenges in Managing Neurotrauma in the Developing World - Vafa Rahimi-Movaghar, Iran
• P6.02: Current management and outcome of spinal trauma in Tanzania - Roger Hartl, United States
• P6.03: Challenges and Opportunities in Managing Neurotrauma in the Developing World - Anthony Figaji, South Africa
• P6.04: Challenges in Managing Neurotrauma in the Developing World – The Ethiopian Experience - Sarah Woodrow, Canada

Chair: Edward Hall, United States

• S13.01: Oxidative Damage is Higher in Hemorrhagic TBIs: Explanation for Selective Benefit of Tirilazad in tSAH Patients - Edward Hall, United States
• S13.02: Regulatory Role of Thioredoxin in autophagy-apoptosis cross talk - Eftekhar Eftekharpour, Canada
• S13.03: Oxidative Lipid Signaling in Neuronal Death Programs in Brain Trauma. - Hülya BayÏr, United States
• S13.04: Aldehyde-mediated neuropathic pain in CNS trauma - Riyi Shi, United States

Chair: Charles Tator, Canada

• S14.01: Christopher Giza, United States
• S14.02: Management of the Sequelae of Repetitive Concussions: Second Impact Syndrome and Postconcussion Syndrome - Charles Tator, Canada
• S14.03: The utility of biomarkers: From the field to the clinic - Jonathon Oliver, United States
• S14.04: Delayed effects of multiple concussions and potential biomarkers of chronic traumatic encephalopathy - Carmela Tartaglia, Canada

Chair: Mayumi Prins, United States

• S15.01: Fueling the TBI Brain - Mayumi Prins, United States
• S15.02: Non-invasive imaging of brain glucose after TBI - Reed Selwyn, United States
• S15.03: Intranasal insulin in the treatment of CNS disorders - Kimberly Byrnes, United States
• S15.04: Insulin Sensitivity after TBI: Implications for Vulnerability to Cerebral Ischemia - Zach Weil, United States
• S15.05: Glucose metabolism in the injured brain - Antonio Belli, United Kingdom

Michael G. Fehlings Fehlings, Canada

• 1.01: Single experimental traumatic brain injury produces progressive chronic histopathological and behavioral deficits up to one year after injury - Xiang Mao, China
• 1.02: Human Apolipoprotein E Isoforms Differentially Influence Neurite Outgrowth and Regeneration - Rachel S.J. Maggard, United States
• 1.03: Recurrent traumatic brain injury surveillance using administrative health data: a Bayesian latent class analysis - Oliver Lasry, Canada
• 1.04: Cervical excitatory neurons restore breathing after high cervical spinal cord injury - Kajana Satkunendrarajah, Canada
• 1.05: Comparison of rescue strategies for brain tissue oxygen tension crisis and their effect on regional microvascular tissue hypoxic fraction - Ari Ercole, United Kingdom

Chair: Patrick Kochanek, United States

• P7.01: Prospects for Axonal Recovery and/or Axonal Regeneration after Spinal Cord Injury - Charles Tator, Canada
• P7.02: What the present informs us of the future of SCI research - reasons to be optimistic - Samuel David, Canada
• P7.03: Mitochondrial-targeted pharmacotherapeutics and biopharmaceuticals for spinal cord injury - Alexander G. Rabchevsky, United States
• P7.04: Optimizing the chance for a future therapeutic breakthrough in the golden age of TBI research - Patrick Kochanek, United States
• P7.05: Recovery Through Manipulation of the Brain's Endogenous Mechanisms - Esther Shohami, Israel

Join us for the NeuroTrauma 2018 Closing and Handover Ceremony.

Chair: Samuel Poloyac, United States

• S16.01: Moving from Disease Target to Lead Compound: Examples in 20-HETE Inhibitor Drug Development - Samuel Poloyac, United States
• S16.02: Pharmacokinetic modeling and neurometabolomics to ensure target engagement - Philip Empey, United States
• S16.03: Using Brain Injury Biomarkers to Indentify Potential Drug Targets. - Gretchen Brophy, United States
• S16.04: Interspecies scaling and Dose optimization: Challenges with Minocycline in acute stroke - Dave Edwards, Canada

Chair: Eve Tsai, Canada

• S17.01: Optimizing the extracellular matrix for neural stem cell-based regeneration in traumatic spinal cord injury - Chris Ahuja, Canada
• S17.02: Can we bioengineering a human spinal cord repair based on rats? - Eve C. Tsai, Canada
• S17.03: Bioengineering scaffolds for cell transplantation after spinal cord injury - Shelly Sakiyama-Elbert, United States
• S17.04: Self-assembling peptides (QL-6) or physical training foster NPC treatment in cervical spinal cord injury - Klaus Zweckberger, Germany

Chair: Lyn Jakeman, United States

• S18.01: Lyn Jakeman, United States
• S18.02: Recycle- Resources and tools to enable new knowledge from open data - Adam Ferguson, United States
• S18.03: Reuse- Challenges and opportunities in harmonizing legacy data - Jessica Nielson, United States
• S18.04: Reduce- Developing laboratory processes to facilitate data sharing - David Magnuson, United States
• S.18.05: Join the movement! - Current status of ODC-SCI - Abel Torres-Espin